Ignite Creation Date:
2024-05-05 @ 12:02 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00227422
Status:
COMPLETED
Last Update Posted:
2016-09-21
First Post:
2005-09-26
Brief Title:
Assess the Non-inferiority of GSK Biologicals Mencevax ACWY Manufactured by a New Process vs Mencevax ACWY the Already Existing Vaccine in the Market When Given as a Single Dose to Subjects Aged 2-30 Yrs
Sponsor:
Organization:
GlaxoSmithKline